MedPath

Effect of Probiotics on diabetes mellitus arising in pregnancy

Phase 2
Conditions
Gestational Diabetes Mellitus.
Diabetes mellitus arising in pregnancy
Registration Number
IRCT201405181597N3
Lead Sponsor
Shahid Beheshti University of Medical Sciences and Health Services
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
64
Inclusion Criteria

nulliparity; diagnosis of gestational diabetes mellitus between 24 weeks and 0 days and 28 weeks and 6 days of pregnancy with oral screening test; fasting blood glucose level between 92- 126 mg/dl; body mass index 18.5 and more; nulliparity; negative history of f diabetes mellitus before the current pregnancy; chronic diseases; Smoking and/or alcohol consumption; probiotic food products consumption through current 2 weeks; antibiotic usage through current month; acute GI condition through current month and glucocorticoid and immunosuppressor drugs usage Exclusion criteria: need for insulin or other hypoglycemic drugs; corticosteroids or immune-suppressants usage or acute GI condition during the study

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fasting Blood Glucose. Timepoint: Before and after intervention. Method of measurement: Enzymatic.;Fasting Plasma Insulin. Timepoint: Before and after intervention. Method of measurement: Elisa.;Homeostatic Model Assessment/HOMA-IR. Timepoint: Before and after intervention. Method of measurement: Calculation.;Quantitative Insulin Sensitivity Check/QUICKI-index. Timepoint: Before and after intervention. Method of measurement: Calculation.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath